News

The United States can no longer keep tabs on drug-resistant gonorrhea, among other infections, scientists said.
If you deal with recurrent UTIs, a new FDA-approved antibiotic called Blujepa could offer another treatment option—especially ...
Under RFK Jr.'s order, the Centers for Disease Control fired all employees of a lab studying STIs and drug resistance to ...
Across primary care practices, guideline adherence remains suboptimal for chlamydia and gonorrhea, according to a study ...
But given gonorrhea’s relentless development of ... said Barbara Van Der Pol, a professor of medicine and public health in the Heersink School of Medicine at the University of Alabama at Birmingham.
The FDA has approved a new at-home test for common sexually transmitted infections and diseases. The test for chlamydia, ...
The Food and Drug Administration (FDA) has cleared the Visby Medical Women’s Sexual Health Test for use at home to test for ...
The FDA on Friday granted marketing authorization to the first at-home test for diagnosing chlamydia, gonorrhea, and ...
Higher treatment rates were seen for females, individuals aged 10 to 29 years, suburban dwellers, and patients with chlamydia-gonorrhea coinfection. HealthDay News — Across primary care ...